Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Doh Yu Hwang, Soo-Jeong Kim, June-Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Yoo Hong Min, Woo Ick Yang & Jin Seok Kim. (2016) High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. Leukemia & Lymphoma 57:1, pages 51-57.
Read now
Read now
Hanne Bersvendsen, Arne Kolstad, Anne Kirsti Blystad, Ellen Aurlien, Alexander Fosså, Stein O. Kvaløy, Harald Holte & Grete F. Lauritzsen. (2014) Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma. Acta Oncologica 53:5, pages 680-687.
Read now
Read now
Patrick Roth, Agnieszka Korfel, Peter Martus & Michael Weller. (2012) Pathogenesis and management of primary CNS lymphoma. Expert Review of Anticancer Therapy 12:5, pages 623-633.
Read now
Read now
Matteo G Carrabba, Michele Reni, Marco Foppoli, Anna Chiara, Alberto Franzin, Letterio Salvatore Politi, Eugenio Villa, Fabio Ciceri & Andrés JM Ferreri. (2010) Treatment approaches for primary CNS lymphomas. Expert Opinion on Pharmacotherapy 11:8, pages 1263-1276.
Read now
Read now
Chi-Chao Chan, Sylvain Fisson & Bahram Bodaghi. (2009) The Future of Primary Intraocular Lymphoma (Retinal Lymphoma). Ocular Immunology and Inflammation 17:6, pages 375-379.
Read now
Read now
Articles from other publishers (32)
Weijun Wang, Nagore I Marín-Ramos, Haiping He, Shan Zeng, Hee-Yeon Cho, Stephen D Swenson, Long Zheng, Alan L Epstein, Axel H Schönthal, Florence M Hofman, Ligang Chen & Thomas C Chen. (2021) NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics. Neuro-Oncology 23:1, pages 63-75.
Crossref
Crossref
Michele Da Broi, Guro Jahr, Klaus Beiske, Harald Holte & Torstein R. Meling. (2018) Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL. Blood Cells, Molecules, and Diseases 73, pages 25-32.
Crossref
Crossref
Kathryn Bower & Nilay Shah. (2018) Primary CNS Burkitt Lymphoma: A Case Report of a 55-Year-Old Cerebral Palsy Patient. Case Reports in Oncological Medicine 2018, pages 1-7.
Crossref
Crossref
Livio Pagano, Caterina G. Valentini, Sara Grammatico & Alessandro Pulsoni. (2016) Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. British Journal of Haematology 174:2, pages 188-202.
Crossref
Crossref
Mehmet Ali Erkurt, Ilhami Berber, Emre Tekgündüz, Mehmet Hilmi Dogu, Serdal Korkmaz, Cengiz Demir, Mehmet Yilmaz, Olga Meltem Akay, Ciğdem Pala, Yusuf Bilen, Emin Kaya, Ismail Sari, Mehmet Sencan, Irfan Kuku, Fevzi Altuntaş, Mehmet Sinan Dal & Ismet Aydogdu. (2016) Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study. Transfusion and Apheresis Science 54:1, pages 80-84.
Crossref
Crossref
B. Kasenda, E. Schorb, K. Fritsch, J. Finke & G. Illerhaus. (2015) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study. Annals of Oncology 26:3, pages 608-611.
Crossref
Crossref
S. Bellefqih, I. Mezouri, J. Khalil, A. Bazine, A. Diakité, H. El Kacimi, T. Kebdani & N. Benjaafar. (2014) Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ?. Cancer/Radiothérapie 18:7, pages 685-692.
Crossref
Crossref
Carole Soussain, Caroline Houillier, Sylvain Choquet & Khê Hoang-Xuan. (2014) Actualités des lymphomes cérébraux primitifs (LCP). Bulletin du Cancer 101:3, pages 314-324.
Crossref
Crossref
Maurizio MussoFerdinando Porretto, Renato Scalone, Alessandra Crescimanno, Vita Polizzi & Vincenza Bonanno. (2014) Novel conditioning regimens for Hodgkin’s and non-Hodgkin’s lymphoma. International Journal of Hematologic Oncology 3:1, pages 63-70.
Crossref
Crossref
Karen Ballen. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
239
245
.
Emerenziana Marturano & Andrés J. M. Ferreri. (2012) Appraisal of recent knowledge in primary central nervous system lymphoma. memo - Magazine of European Medical Oncology 5:4, pages 285-288.
Crossref
Crossref
B. Kasenda, E. Schorb, K. Fritsch, J. Finke & G. Illerhaus. (2012) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study. Annals of Oncology 23:10, pages 2670-2675.
Crossref
Crossref
R L Tombleson, M R Green & K M Fancher. (2012) Putting caution in TEAM: high-dose chemotherapy with autologous HSCT for primary central nervous system lymphoma. Bone Marrow Transplantation 47:10, pages 1383-1384.
Crossref
Crossref
N Reddy & B N Savani. (2011) Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT. Bone Marrow Transplantation 47:10, pages 1265-1268.
Crossref
Crossref
Andrés J.M. Ferreri & Emerenziana Marturano. (2012) Primary CNS lymphoma. Best Practice & Research Clinical Haematology 25:1, pages 119-130.
Crossref
Crossref
Cheolwon SuhJeong Eun KimDok Hyun Yoon. (2012) Relapse pattern and prognostic factors for patients with primary CNS lymphoma. The Korean Journal of Hematology 47:2, pages 155.
Crossref
Crossref
Jeong Eun KimDok Hyun YoonShin KimDae Ho LeeJeong Hoon KimYoung Hee YoonHyun Sook ChiSang Wook LeeChan-Sik ParkJooryung HuhCheolwon Suh. (2012) Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma. The Korean Journal of Hematology 47:1, pages 60.
Crossref
Crossref
Prathima ProdduturiPhilip J Bierman. (2012) Current and Emerging Pharmacotherapies for Primary CNS Lymphoma. Clinical Medicine Insights: Oncology 6, pages CMO.S7752.
Crossref
Crossref
Eudocia C. Quant, David C. Fisher & Patrick Y. Wen. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
357
381
.
Taekyu Lim, Seok Jin Kim, Kihyun Kim, Jung-Il Lee, Do Hoon Lim, Duk Joo Lee, Kyung Kee Baek, Ha Yeon Lee, Boram Han, Ji Eun Uhm, Young Hyeh Ko & Won Seog Kim. (2011) Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Annals of Hematology 90:12, pages 1391-1398.
Crossref
Crossref
Andrés J. M. Ferreri. (2011) How I treat primary CNS lymphoma. Blood 118:3, pages 510-522.
Crossref
Crossref
E. Marturano & A.J. Ferreri. (2011) V. Primary CNS lymphoma in immunocompetent patients. Annals of Oncology 22, pages iv41-iv43.
Crossref
Crossref
Benjamin Kasenda, Elisabeth Schorb, Kristina Fritsch, Claudia Hader, J?rgen Finke & Gerald Illerhaus. (2011) Primary CNS Lymphoma?Radiation-Free Salvage Therapy by Second Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 17:2, pages 281-283.
Crossref
Crossref
Christopher J. Campen, Rebecca L. Tombleson & Myke R. Green. (2010) High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma. Journal of Neuro-Oncology 101:3, pages 345-355.
Crossref
Crossref
Kang Hyun SungEun Hee LeeYoung Zoon Kim. (2011) Factors Influencing the Response to High Dose Methotrexate-based Vincristine and Procarbazine Combination Chemotherapy for Primary Central Nervous System Lymphoma. Journal of Korean Medical Science 26:4, pages 551.
Crossref
Crossref
D H Yoon, D H Lee, D R Choi, B S Sohn, S Kim, S W Kim, J S Lee, S W Lee, J Huh & C Suh. (2010) Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience. Bone Marrow Transplantation 46:1, pages 105-109.
Crossref
Crossref
Amish C. Shah, David R. Kelly, L. Burt Nabors, W. Jerry Oakes, Lee M. Hilliard & Alyssa T. Reddy. (2010) Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients. Pediatric Blood & Cancer 55:6, pages 1227-1230.
Crossref
Crossref
Andrés J. M. Ferreri, Gerald Illerhaus, Emanuele Zucca & Franco Cavalli. (2010) Flows and flaws in primary central nervous system lymphoma. Nature Reviews Clinical Oncology 7:8, pages 1-2.
Crossref
Crossref
Nooshin Hashemi-Sadraei & David M. Peereboom. (2010) Review: Chemotherapy in newly diagnosed primary central nervous system lymphoma. Therapeutic Advances in Medical Oncology 2:4, pages 273-292.
Crossref
Crossref
Andrés JM Ferreri, Michele Reni, Marco Foppoli, Maurizio Martelli, Gerasimus A Pangalis, Maurizio Frezzato, Maria Giuseppina Cabras, Alberto Fabbri, Gaetano Corazzelli, Fiorella Ilariucci, Giuseppe Rossi, Riccardo Soffietti, Caterina Stelitano, Daniele Vallisa, Francesco Zaja, Lucía Zoppegno, Gian Marco Aondio, Giuseppe Avvisati, Monica Balzarotti, Alba A Brandes, José Fajardo, Henry Gomez, Attilio Guarini, Graziella Pinotti, Luigi Rigacci, Catrina Uhlmann, Piero Picozzi, Paolo Vezzulli, Maurilio Ponzoni, Emanuele Zucca, Federico Caligaris-Cappio & Franco Cavalli. (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. The Lancet 374:9700, pages 1512-1520.
Crossref
Crossref
Amelia Ramon-Lopez, Ricardo Nalda-Molina, Belen Valenzuela & Juan Jose Perez-Ruixo. (2009) Semi-Mechanistic Model for Neutropenia after High Dose of Chemotherapy in Breast Cancer Patients. Pharmaceutical Research 26:8, pages 1952-1962.
Crossref
Crossref
Patrick G Morris & Lauren E Abrey. (2009) Therapeutic challenges in primary CNS lymphoma. The Lancet Neurology 8:6, pages 581-592.
Crossref
Crossref